Secretary General and Treasurer, International Society of Impotence Research, an endocrinologist from Lille, France, was also invited to the inaugural meeting in Nairobi, Kenya but had been involved in a serious motor vehicle accident and could not attend this meeting.
During the plenary sessions, up to date knowledge on erectile dysfunction, female sexual dysfunction and the very important and controversial practice or malpractice of female circumcision or female genital mutilation was presented and discussed. Prof R Lewis discussed the epidemiology, the future and advances in management of ED and experiences with in¯atable penile implants. The hemodynamics and pathophysiology of erection and the pharmacological treatment of ejaculatory dysfunction were presented by Dr C McMahon, while Prof R Shabsigh discussed oral, intracavernous and intra-urethral treatment of ED and female sexual dysfunction in partners with ED. Prof I Sharlip discussed reasons why approximately 9% improvement is noticed in impotent men using intracavernous injections. He ascribed the spontaneous improvement to a psychogenic effect or variations in erectile function, rather than a physiologic effect. However, intracavernous injections started soon after radical prostatectomy may have a protective effect in preserving normal erectile function. He also gave an overview of female sexual dysfunction. Prof E Austoni covered penile revascularisation, penile preservation in cancer surgery, his techniques for enlargement of the penis, surgery in Peyronie's disease and transsexual surgery, while Prof J Pryor presented experience with different operations for Peyronie's disease. Professors M El Refaei and K Matar and Dr KL Dabees, respectively, presented lectures on nerve sparing urethroplasty in posterior urethral surgery, new challenges in the management of surgical infection and malleable penile implants. Dr R El-Rashidy presented experience with Apomorphine in ED and medical treatment of Premature Ejaculation.
Very interesting original papers were presented during the podium sessions. Dr A El-Saka of UCSF and the Suez Canal University reported that erectile function and NO synthase containing ®bers in the dorsal and intracavernous nerves were decreased in diabetic rats. The same group reported that TGF-b1 protein expression is associated with Peyronie's disease in humans. Dr KM Badr and associates from Egypt reported on induced hypercholesterolemia in rabbits and developed a model of vasculogenic impotence that was effectively treated with oral L-arginine. Dr RM Seyam and associates, from the Suez Canal University in collaboration with McGill University, Montreal, Quebec reported that nNOS is more abundant in the major pelvic ganglion, crura of the penis and pelvic urethra and eNOS more abundant in the urethra and to a lesser extent the penis of the rat.
Dr IP Levinson from South Africa reported that intermittent combined androgen blockade leads to improved sexual function and quality of life in prostate carcinoma patients. Prof S Kattan from Saudi Arabia delivered a very interesting paper on his experience on impotence in the Arab world. He studied a consecutive group of 250 patients with a mean age of 52.8 y. The age difference between the patients and their spouses ranged from minus 1±46 y (mean 16 y). In this group, 35.7% had mild, 21.8% moderate and 42.4% severe ED. The most common risk factors were old age, DM, smoking and cardiovascular disease. Intracavernous pharmacotherapy had the highest acceptance rate (71.8%), penile prostheses had the highest long-term acceptance rate and vacuum constrictor devices had the highest drop-out rate. Acceptance and satisfaction with treatment were directly related to the degree of ED, number of wives and age difference between patients and spouses.
Dr M Rosello from Spain reported on digitalised axial rigidometry as measured by a new electronic device. He found this the only equipment capable of reliably measuring axial rigidity, relative intracavernosal pressure and glans temperature. He also presented a paper on diagnosis of male and female sexual dysfunction. Penile axial rigidity and vaginal introitus resistance were measured. He found higher female introitus resistance than penile axial rigidity and concluded that this may be an indication for treatment of atrophic vaginitis and dyspareunia with hormones or lubricants. He presented two other papers on treatment of patients with ®brosis of the corpus cavernosum. In the ®rst paper corporeal ®brosis was treated effectively with a vacuum constricting device and in the other a new disposable cavernotome was used successfully as an aid for corporeal dilatation during implantation of penile prosthesis in patients with severe corporal ®brosis. Dr FM Kharmis from Egypt reported functional impairment of smooth muscle contractility and relaxation to neurogenic stimulation in strips of cavernous muscle obtained from patients with abnormal penile hemodynamics. He concluded that these observations might be a factor in the poor results obtained with vascular surgery.
Dr AK Fahmy and associates from Coventry, UK reported that measurement of testosterone was not helpful in their study of 96 consecutive men attending a ED clinic. The testosterone results did not help in assessing potency or libido and low testosterone levels were not age related, nor did therapeutic correction of testosterone improve impotence or libido. Dr MA Helal and associates from the Institute of Urology presented a study of 21 patients (mean age 32 y) between 1991 and 1998 with anejaculation as a fertility problem, this was successfully treated with Yohimbine. Some patients needed a vibrator to ejaculate.
Dr K Nyarko from South Africa reported that 4 mg PGE1 was an effective initial dose in 80% of 32 consecutive patients who attended an ED clinic. He concluded that this dose was safe and cost effective. Dr H Halwagy from Port Said, Egypt reported that intracorporeal injections were popular, in spite of effective oral therapy or alternative methods of delivery of vasoactive agents. He stated that chlorpromazine may be used to substitute phentolamine in a mixture with papaverine. Chlorpromazine is cheaper and just as effective as phentolamine. Two papers were presented on the successful use of arti®cial devices in delivering vasoactive agents. These devices avoided multiple corporeal punctures. Dr AM Helmy from Saudi Arabia reported his experience with 480 patients between 1987 and 1995 and Dr MA Helal from the Institute of Urology, reported on 21 patients. Complications were reported and he mentioned that devices were active for a minimum of 3 y. In a comparative study on 98 patients with psychogenic impotence (honeymoon impotence), Dr Abu-Elfetouh El Shaer and associates from Tanta University, Egypt, found that oral sildena®l was more effective, with fewer complications than intracavernous injection of a papaverinephentolamine mixture.
Two papers were delivered on penile vascular surgery. In the ®rst Prof H Biedermann from Austria reported his long-term experience with ®ve patients from a very large group of 130 operated patients. He reported his complications and concluded that successful repair procedures may be attempted even after 10 y. In the second paper presented by Dr A Ezzat from the Urology Department, Assiut, Egypt and University of Boston, US, reported on 50 patients who were divided into three groups according to the size of branches between the deep dorsal artery and the cavernous tissue. Their success rate with microscopic revascularisation of the inferior epigastric artery to the deep dorsal artery was 100% in the those with adequate branches to the cavernous tissue, 75% with inadequate branches and 40% where no branches were noted. They recommend penile revascularisation in young males with arteriogenic impotence and no vascular risk factors.
Two papers were delivered on studies of penile fractures. The ®rst included 53 patients and was delivered by Dr MS El-Bahnasy from Mansoura, Egypt. He reported excellent results with early surgical repair, only three patients (less than 5%) experienced reduced erectile rigidity. The other study was presented by Dr P Gontero, King's College Hospital, London, UK. He reported on ultrasound African Society for Impotence Research Ð Second continental meeting investigation in four patients after surgical repair of penile fracture. Hyperechogenic spots were observed, produced by non-absorbable suture material, but no changes indicated Peyronie's disease. Arterial¯ow was normal in all patients, including two with reduced erectile function. Increased enddiastolic¯ow, indicating venous leakage, was noted in one.
Dr SA Helmy and associates from Tanta University, Egypt reported their experience with phalloplasty. They found that reconstruction with a free lateral forearm¯ap produced a fully functioning penis with excellent patient satisfaction. Dr KL Dabees reported reconstruction of an amputated penis with a lipo-dermal¯ap.
Seven papers were presented from work at the Institute of Urology, UK. Dr MA Helal, reported on plaque incision and vein grafting for Peyronie's disease according to the Lue technique. They found the technique excellent for patients who do not wish to lose penile length. Dr OH Andrews reported on 30 patients with more than 30 degree angulation, from a group of 344 patients who had previous Nesbit operations. Different techniques were used to correct the problem and he concluded that the Nesbit operation should only be performed with normal erectile capacity and no signs of active disease. He stressed the importance of non-absorbable sutures and remarked that patients should be warned about penile shortening. Dr IA Mokhless reported on corporoplasty in congenital penile curvature and penile lengthening and advancement. They found the Nesbit procedure more successful for curvature correction, but incisional corporoplasty easier, simpler and safer. A combined surgical approach including division of the suspensory ligament of the penis, liposuction of prepubic fat and a ventral Z-skin-plasty at the penoscrotal web was used for penile augmentation. Dr C Bettocchi reported on the successful use of buccal mucosa for neourethral repair in phalloplasties in 65 female to male transsexuals.
Two symposia were held. In the ®rst, sponsored by P®zer,`New horizons in management of ED', was discussed by Prof R Shabsigh, Dr W Gurigus from the UK and Dr I Levinson from South Africa. The other, sponsored by Janssen Cilag, on intra-urethral therapy in ED, was focused on the ef®cacy and safety of MUSE and presented by Dr M El-Hellaly from Canada and Dr N Metry from the UK.
The Introduction: Direct determination of nitric oxide synthase (NOS) and its transcription machinery among definite structures of the lower urinary tract and within each crucial to our interpretation of its physiologic role. We utilized the specific and quantitative techniques of Western and Northern blotting to determine the relative content of neuronal NOS (nNOS) and endothelial-NOS (eNOS) proteins and mRNAs in the various parts of the penis and lower urinary tract. Methods: Six normal adult male Sprague-Dawley rats supplied the following tissues: major pelvic ganglion (MPG), dorsal neurovascular bundle (NVB), shaft of penis, crura of penis, distal penile urethra, pelvic urethra, urinary bladder, ventral prostate and dorsolateral prostate. Six samples of each structure were pooled and evaluated for protein content of nNOS and eNOS by Westernblotting. We evaluated nNOS and eNOS mRNA by Northern-blotting. The cerebellum was evaluated as a control. Densitometry scanning of the blots was carried out.
Results: nNOS protein was detected in abundance in the MPG, cerebellum, pelvic urethra and crura of the penis. The penile urethra, NVB, the shaft of penis and dorsolateral prostate contained smaller amounts of protein and none was found in the ventral prostate and urinary bladder. nNOS mRNA was detected in the MPG, cerebellum, pelvic urethra and crura of penis. cNOS protein was most abundant in the penile and pelvic parts of the urethra and urinary bladder: a moderate content was found in the crura, penile shaft, NVB and MPG; whereas the prostate had none. Similarly eNOS mRNA was abundant in MPG, penile urethra, pelvic urethra and cerebellum; penile shaft and crura, NVB and bladder showed moderate amount; whereas none could be found in the prostate.
Conclusions: nNOS and its mRNA are most abundant in the MPG, crura of penis and pelvic urethra whereas eNOS is most abundant in the urethra and to a lesser extent present in the penis. Importantly eNOS protein and mRNA were demonstrated in the MPG, where eNOS-function has to be studied.
Erectile Dysfunction and Quality of Life in Patients on Intermittent Combined Androgen Blockade for Stage C or D Carcinoma of the Prostate

IP Levinson
Mediclinic Hospital, South Africa Introduction: A recent postulate which is currently been tested in randomised placebo controlled trials is the intermittent treatment of disseminated Prostate cancer via combined androgen blockade. It is hoped that this treatment will not only be equivalent to the results obtained with permanent blockade but may in fact be superior in terms of disease free survival and length of survival. Secondary outcomes should also measure the patients quality of life and maintenance of erectile function. Methods: With this in mind 1±5 patients with stage C and D Prostate cancer (biopsy positive and routine staging) treated over the last 4 y via intermittent androgen blockade was conducted. This looks at the aspects of vitality of life and erectile function in these patients. Each patient acted as their own control. They were treated with a combination of an LHRH agonist (Leuprolide) and an antigandrogen (either Flutamide or Bicalutamide) if their PSA rose above a preset level or if they developed symptoms suggestive of progressive disease. The treatment continued until a PSA nadir was reached and it was then stopped until the next treatment schedule became necessary. Intervals between treatment schedules varied from 3±15 months with a mean of five months and depend on the aggressiveness of each tumour (assessed by symptoms andaor a rising PSA). Routine evaluation took place every three
African Society for Impotence Research Ð Second continental meeting months whilst off treatment and monthly whilst on treatment. Erectile function was assessed via a simple questionnaire and was subjectively evaluated by the patient. More recently questions 3 and 4 of the HEF has been used. Vitality and quality of life was assessed via quality of life questions, an assessment of libido and an overall sexual satisfaction question.
Results: As recently shown the effect on libido and erections can take between 30±60 d from the onset of treatment but concomitantly may last for the same length of time on stopping the treatment. Nevertheless it did return in all patients who had no problems prior to the onset of treatment, although there was a slow drop off in magnitude over the period of the trial. Vitality of life remained excellent in ill patients whether on or off treatment. This was possibly due to the fact that they were aware that they were on treatment for a limited period of time only (that is, until the PSA dropped). If there was a deterioration in control using intermittent blockade the vitality index did drop. The overall quality of life remained excellent in all patients except those in whom the control deteriorated resulting in an uncontrolled rise in the PSA. This was obviously related to tumour control, maintenance of libido and erections, periods off active medication and hence reduced costs and maintenance of vitality. There was a marginal drop off in quality of life indices during the periods on active medication. Conclusion: Although still to be proven that intermittent androgen blockade is equal to or in fact superior to continuous blockade in terms of tumour control and survival, it seems from this small trial that it has something to offer with regard to sexual functions and quality of life issues.
Corpus Cavernosal Relaxation in Impotence
FM Khamis
Consultant Dermatology and Andrology
Objective: To investigate smooth muscle responsiveness in isolated preparations of corpus cavernosum from men with vasculogenic impotence. Patients and methods: Biopsies of corpus cavernosum were obtained from 63 men undergoing penile surgery. These included a control group of eight men (mean age 59 y, range 38±82 y) undergoing penile amputation of carcinoma, 47 men with vasculogenic impotence (mean age 58 y, range 36± 72 y) who were further sub-divided into arterial (n 9), venous (n 24) or mixed arterialavenous (n 14) impotence according to the results of preoperative haemodynamic investigation, and eight men with nonvasculogenic impotence (mean age 49 y, range 34±66 y). Smooth muscle contractile responses to alpha adrenoceptors activation and relaxant responses to stimulation of intrinsic nerves and exposure to papaverine and sodium nitroprusside were recorded in tissue strips prepared from the biopsies. Morphology was assessed histologically using haematoxilin and eosin staining of tissue sections together with immunocytochemical labelling of intrinsic nerves.
Results: Nerve-evoked relaxation was markedly impaired in tissue from men with venous or mixed arterialavenous impotence. A lesser degree of impairment was found in tissue from men with arterial impotence alone. Tissue from men with all types of vasculogenic impotence also showed a decreased contractile response to alpha-adrenoceptor stimulation. The magnitude of relaxant responses to papaverine and sodium nitroprusside in the vasculogenic group was similar to that of the control. There were no differences in smooth muscle content or nerve density between the vasculogenic group and the control. In the non-vasculogenic group responses to relaxant nerve stimulation, alphaadrenoceptor activation and relaxant drugs were similar to those of the control. Nerve density in this group was similar to the control but smooth muscle content was reduced.
Conclusions:
The results of this study demonstrate a functional impairment of smooth muscle contractility and neurogenic relaxation in corpus cavernosum from impotent men with abnormal penile haemodynamics. Altered smooth muscle responsiveness is likely to be a factor in the aetiology of impotence in such men and may contribute to the relatively poor results of vascular surgery for impotence.
Impotence in the Arab World
S Kattan
Associate Professor of Urology, Consultant Urologist A retrospective study was designed to study the characteristics of Saudi patients presented with impotence, and to evaluate the outcome of various treatment options. A consecutive group of 250 Saudi patients presenting with impotence to the Erectile Dysfunction Clinic were studied. The mean age of patients was 52.8 y.
Polygamy was practised by 21.8% of the patients. The age span between the patient and his spouses ranged between minus 1 and 46 y, mean 16 y.
The presenting degree of impotence was mild, moderate and severe in 35.7%, 21.8% and 42.4% of patients respectively.
Old age, diabetes, smoking, and cardiovascular disease were the most prevalent risk factor while arterial insuf®ciency was the most common etiological diagnosis.
Vasoactive intracavernous pharmacotherapy enjoyed the highest initial acceptance rate of 71.8% while patients who underwent penile prosthesis African Society for Impotence Research Ð Second continental meeting insertion had the highest long-term satisfaction rate. Penile vacuum device had the highest drop rate.
Acceptance and satisfaction of patients with the intracavernous pharmacological treatment and penile prosthesis surgery was directly related to the degree of impotence, number of current wives and the age difference between the patients and their spouses. Objectives: We aim to demonstrate that the DIR, used by the patient himself either at the clinic or at home will provide accurately, in a non-invasive and fast way the penile axial rigidity in grammes, the relative intracavernosal pressure and the glans temperature. Method: Fifteen impotent patients were evaluated. We used DIR, Rigiscan and Eco-Doppler in the diagnosis process. Patients were divided into two groups A, 8 patients and B, 7 patients. We injected both groups 15 mcgs PGE1. Patients from group A were monitorized with the Rigiscan, advising them, that in case they had an erection, they should use the DIR with a frequency of five minutes. EcoDoppler evaluation and axial rigidometry were applied to group B. Measurements were made when there was some rigidity. Results: From group A, in three cases the Rigiscan showed a circumferential rigidity between 60 and 80% which did not correlate to the axial rigidity achieved between 300 and 400 g. The Eco-Doppler evaluation showed a normal vascular anatomic parameters but did not correspond to a normal axial rigidity, about 500 g.
Digitalised Axial
Conclusions:
The DIR has proved to be the only equipment able to measure reliably the axial rigidity the relative intracavernosal pressure and the glans temperature in a non-invasive way and it offers the possibility of being used by the patient himself either at the clinic or at home.
Is Measurement of Serum Testosterone Routinely Indicated in Men with Erectile Dysfunction
AK Fahmy, SM Mitra, RE Blaklock and KM Desai Walsgrave Hospitals NHS Trust, Coventry, UK Introduction: Testosterone is known to enhance libido, frequency of sexual intercourse and sleeprelated erections. Its effect on erotic arousal and psychically mediated erection is poorly understood. It is not clear from previous studies whether serum testosterone level is a relevant or useful indicator of sexual potency. We have studied serum testosterone levels in relation to potency status in men attending our erectile dysfunction clinic. Patients and methods: Ninety consecutive men attending the erectile dysfunction clinic completed a sexual activity questionnaire and underwent a focused physical examination and questioning regarding medical history. Serum testosterone level was measured in all patients and the results analysed in relation to the patient's age. Patients with low serum testosterone commenced replacement therapy comprising three intramuscular injections of sustanon 250 mg every third week. potency status and serum testosterone were reassessed after three months' treatment. Results: Twenty-eight (31%) of the 90 men were aged under 50 y whilst 62 (69%) were 50 y old or over. Nineteen (21%) patients overall had low testosterone levels: 4 of these were under 50 y old and 15 were 50 y old or over. Five out of 90 patients had decreased libido; 2 of these also had low testosterone and all were in the under 50 y age group. Testosterone levels returned to normal in all patients who received replacement therapy however potency returned only in 2 (10%); both were in the older age group. Conclusion: Measuring testosterone was not helpful in assessing potency or libido and low serum levels were not age-related. Correcting low testosterone did not improve either impotence or libido. Introduction and objectives: Atrofic vaginitis in menopausic women results in an increase of the vaginal introitus resistance. Such resistance could mislead to a wrong diagnosis of his partner impotence. We aim to demonstrate the usefulness of the Digital Inflection Rigidometer (DIR) in assessing the penile axial rigidity (PAR) needed by a man to penetrate his partner. That is her vaginal introitus resistance to penetration. Methods and materials: A total of eight men with erectile dysfunction were studied. Their average age range 50±60 y. A completed blood analysis, including hormonal test, was performed. Explorations also included PAR measured by himself with the DIR after an intracavernosal injection of 15 mcg PGE1
Diagnosis of Male and Female Sexual
African Society for Impotence Research Ð Second continental meeting and measurement of penile circumference and length. Their partners' explorations included a vaginal tactus in order to determine the vaginal introitus capacity. When measuring the introitus resistance, women were instructed to replace the DIR measuring sensor for a special device that would hold a silicone penis of the same characteristics of her partner's penile anatomy. Results: The average PAR in men ranged 600±800 g, which is considered sufficient as to penetrate a well lubricated virgin, while in women the introitus resistance ranged 900±1200 g. Rest of the parameters were normal. Conclusion: The DIR provides for the first time and in a reliable painless way the PAR that a man needs to penetrate his partner. We explain the patients the relevance of avoiding atrofic vaginitis and dyspareunia with hormonal treatment, if indicated, or by extra-lubricating the vagina.
Medical Treatment of Anejaculation
AA Adeniyi, MA Helal, HO Andrews, DJ Ralph and GS Brindley
Institute of Urology
Introduction and objectives: Patients with anejaculation often present with infertility and need assisted conception with sperm retrieval procedures. An attempt was therefore made to alleviate this using Yohimbine. Materials and methods: Between 1991 and 1998, 21 patients with anejaculation (mean age 32.4 y) were reviewed. Yohimbine was first administered in the clinic under supervision and then patients were allowed to increase the dose at home (titration) under more conductive circumstances. The outcome was subsequently assessed. A note was made of side effects experienced. Fifteen had primary anejaculation and five had secondary. Nocturnal emissions were present in 53.3% with erectile dysfunction (ED) in 40%. The paramount reason for concern was fertility (70%), the other being normality of the sexual experience (30%). Results: It was considered successful in 9 out of the 14 patients (64.3%) that had completed the treatment trial (that is, they were able to ejaculate after taking the medication during masturbation or sexual intercourse). Among the five considered unsuccessful, three ejaculated using Yohimbine with the added assistance of a vibrator. If included, this would then give a combined success rate of 85.7% of the successes, two needed titration of the drug at home before it was successful, two have had successful pregnancies (1 twin delivery) and three were cured, no longer requiring Yohimbine before successful ejaculation). Side effects included dartos contraction tremor palpitations malaise nausea and headache but were not a significant deterrent in any patient.
Conclusions: Medical correction of anejaculation with Yohimbine is a successful alternative to other means of assisted conception and sperm retrieval.
Response to a Low Intracavernous Dose of PGE 1
JK Nyarko and AC Schmidt
University of Stellenbosch and Tygerberg Hospital, South Africa Introduction: PGE 1 has been accepted as effective treatment for erectile dysfunction in our clinic. Two problems associated with the use of intracavernous injection (ici) of PEG 1 in are establishing the effective dose for each patient and the cost of the PGE 1. Aim: To assess the response in our patient population to a minimum, easy to measure ici dose. Patients and methods: 32 consecutive new patients that presented to the sexual dysfunction clinic, all seen by one doctor, were included in this study. 4 mg of PGE 1 was used as the initial ici, followed by self stimulation. The response was assessed every five minutes and classified as a percentage of a normal erection, by the same doctor. When necessary the dose was increased by increments of 4 mg, if the response was not satisfactory. Results: 25 patients (78%) had a greater than 80% response within 30 minutes after ici. 24 of these patients had an 80% response within 5 minutes. 7 (22%) had less than 80% response within 30 min, two failures at 4 mg (29%) responded 100% to 8 mg and five had less than 80% response. Three failures at 8 mg responded b 80% to 10 mg and two were less than 80% of failures at 10 mg responded to 20 mg with b 90% and one less than 60%. No case of priapism was noted in this study. None reported back with problems of measurement of the dose. Cost: Each syringe cost $9. If 4 mg is effective, each dose costs $1.8. Conclusion: 4 mg was an effective initial dose in about 80% of the patients. Low dose ici of PGE 1 was well accepted, effective, safe and cost effective treatment for erectile dysfunction in this patient population.
New Developments in Self-Injection Therapy for Erectile Dysfunction
H Halwagy Port Said, Egypt
Introduction: There can be no doubt that the discovery of the use of intra-corporeal vasoactive agents has revolutionized the management of erecAfrican Society for Impotence Research Ð Second continental meeting tile dysfunction (ED). The use of intracorporeal papaverine, papaverineaphentolamine mixtures have been widely reported for both the diagnosis and therapy of impotence. The first reported self injection programme by Zorgniotti and Lefleur using a combination of papaverine and phentolamine showed that this was not only a safe but also a satisfactory and successful treatment of ED for many patients. These findings have since been confirmed by many large published series and self-injection of vasoactive agents has formed the mainstay of treatment for ED over the past 10 y. New review: Chlorpromazine has been shown to be a useful substitute for phentolamine when used in combination with papaverine in the treatment of ED. The response was fully erection, sexual satisfactory to the patient.
The advantage of the alpha-blocker chlorpromazine over phentolamine is the reduced cost of the drug with the same effectiveness if not better in recorded cases. Conclusion: In spite of the fact that with the development of effective oral agents for ED and alternative methods of delivery of vasoactive agents via transdermal and peruretheral application, the use of intracorporeal agents retain role in ED.
Remote Intracorporeal Injection for Treating Impotence
AM Helmy
Consultant Urologist, Dr Helmy's Clinic, Jeddah, Saudi Arabia
The intracorporeal injection of vasoactive drugs to induce erection and by-pass all the yet undiscovered causes of impotence has been shown to be a good and safe palliative method for treating impotence. Self intracavernous injection (SICI), which is the most convenient way to deliver the drugs is often dif®cult and carries the risk of corporeal multipuncture. To overcome these particular dif®culties and risks, a special device was invented and successfully implanted in 480 patients between January 1987 and June 1995. Introduction: This penile drug delivery implants consists of a cannula which is inserted into the corpus cavernosus and a combined scrotal reservoir and a pump containing a vasoactive drug. Compression of the reservoir pump distributes a bolus of vasoactive agent to the penis and stimulates an erectile response. The first implants was inserted in 1986 and we now present our long term follow up of 36 devices inserted in 21 patients. Patients and methods: The mean age of the patients was 42 y (range 20±63 y) and the initial diagnosis of the erectile dysfunction was psychogenic (9), neurogenic (10) and post surgical (2). The initial drugs used within the reservoir were papaverine and phentolamine but it soon became apparent that crystal formation caused tubal blockage and these have been replaced with Sodium Nitroprusside which is stable at body temperature. Results: When active, the device worked extremely well giving an excellent quality erection. The implants remained active for a mean duration of 14 ms (range 0±82 ms) and eight of the devices are still functional with mean follow-up of 4 y. The reason for failure included leaking reservoir (7), blocked tubes (6), mechanical failure (9) and infection (3). Only two patients developed priapism using the device. One of which managed conservatively and the other needed a penile prosthesis. With modifications of the device over the last 10 y. Patients can now expect the device to be active for a minimum of 3 y. And it is an ideal alternative to self injection.
Comparative Study Between Intracorporeal Vasoactive Drug Versus Sildena®l`Viagra' in Management of Psychogenic Impotence (honeymoon impotence): A Randomized Prospectived Study
A-E Alshaer, MR Taha, A Hassan, M Sabaa, A Elbahnsay and S Elabd Tanta University, Egypt Psychogenic impotence occurs in a good percentage in the community, specially in the ®rst sexual relation in islamic man's life (honey-moon impotence). In this study, 98 patients with documented psychogenic impotence were randomized into one of two groups according to method of treatment. In the ®rst group (Group A), 40 patients were managed with sildena®l`Viagra' 50 mg orally. In the second group (Group B), 58 patients were managed by intercorporeal injection of 30 mg papaverine plus 0.5 mg phentolamine. The patients were age matched in both groups. The success rate (achieving good erection enough for vaginal penetration) was signi®cantly higher in group A than group B, 93% vs 71% respectively (P`0.05). The complications rate was signi®cantly higher in Group B than Group A, 28% versus 12%, respectively. Priapism occurred in six patients (10%) in group B and all patients were managed conservatively. On the other hand, we encountered 100% patient's satisfaction in group A vs 78% in group B.
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Conclusion: From this study we concluded that oral sildenafil (Viagra) and intracorporeal injection of papaverine-phentolamine are both effective in management of psychogenic impotence (honey-moon impotence). However, Viagra is found to be more effective, have less complications rate and more convenient to the patient. Objectives: The purpose of this study is to demonstrate that using the electronic Vacuum Plus Treatment (VPT), when a passive erection is induced and sustained for a period of time, the inflow of oxygenated arterial blood in the penis, during a determined period of time, will improve the extensivity and elasticity of all vascular-structures of the corpus cavernosum. Method: Fifteen patients with erectile dysfunction of an ischaemic etiology underwent a 90 d treatment programme with known negatives pressures starting at 75 mmHg and increasing progressively until reaching 250 mmHg. The patients used it daily, 15 times in the morning and 15 times in the night, forcing a total of 30 erections of one minute each (45 s of rigidity and 15 s of release). Oxygen concentration in the penile blood was measured the first and the last day of the 90 d treatment.
Corpus Cavernosum Fibrosis Treated with
Results: All 15 patients recuperated their morning erections. Their erective capacity also improved (axial rigidity parameters above 500 g). Seven patients could maintain sexual intercourse at the end of treatment with no need of the vacuum device. Conclusion: Those results suggest that the VPT is a non invasive vacuum therapy to prevent and cure corpus cavernosum fibrosis. Introduction: Invasive therapy is indicated in selected cases of vasculogenic impotence where (semi-)conservative treatment is ineffective, precarious or not accepted. There are only few reports in the literature concerning long term results after formation of penile arteriovenous fistulae. Especially morphologic changes have rarely been described. Materials and methods: From a series of more than 130 operated patients five (age 32±50 y at the initial operation, four vein grafts and one epigastric artery bypass) have been investigated up to about ten years by color duplex ultrasound and angiography. Two patients had a hypervascularisation syndrome and needed banding of the bypass. In one case a second bypass had to be installed because of occlusion and erectile dysfunction after 9.5 y. In one patient the peripherally occluded deep dorsal vein had to be removed and the crura penis ligated because of transient erectile dysfunction. In two cases an aneurysm of the venous bypass had to be resected 9 and 10 y respectively, after surgery. Results: After a mean follow-up period of 10.6 y three patients were able to have normal and two sufficient sexual intercourse. All bypasses were patent, however the peripheral deep dorsal vein was occluded in two cases. Discussion and conclusions: In successful arteriovenous fistulae to the deep dorsal penile vein dilatation, stenosis or occlusion can occur. Color duplex sonography represents the method of choice for early detection of postoperative change. A new bypass can only be performed in cases with a patent deep dorsal vein.`Service' operations are even effective after a 10 y period, in particular in younger men.
The Role of Penile Revascularization in Treatment of Impotence
A Ezzat, AM Essam, E Osman, MA Shalaby and I Goldstein Urology Department, Assut Egypt and University Boston, USA There are over 100 different variations of surgeries entitled`penile revascularization surgery'. Lack of standardized techniques and selection criteria may have contributed to the current low popularity of arterial revascularization such that no one procedure has been universally accepted.
The goal of this work is to identify if this therapeutic modality is able to achieve acceptance as a safe reliable, ef®cacious and predictable treatment option for the impotent male under conditions of de®ned indications selection criteria and surgical technique for penile revascularization surgery.
This study included 50 patients complaining of erectile dysfunction of pore arteriogenic etiology with mean age of 35 AE 12 y. The patients were divided into three groups. The ®rst group with a African Society for Impotence Research Ð Second continental meeting branch of approximate size from the deep dorsal artery to the cavernous tissue and the second group with small branches from deep dorsal artery to the cavernous tissue and the third group with no branches from deep dorsal artery to the cavernous tissue. All patients underwent microvascular arterial bypass surgery with the interior epigastric artery anastomosed to the dorsal artery of the penis using strict patient selection and endothelial-sparing surgical technique. All patients were followed up for a period of 6 months to 24 months with a mean duration of 17 months.
The success rate in the ®rst group was 100% compared to 75% and 40% in the second and the third group respectively.
We recommend penile revascularization for young patients with pure arteriogenic impotence with no vascular risk factors. The factor predicting success of surgery is the presence of a branch from the dorsal artery to the cavernous tissue.
Penile Prosthesis Implant in Case of Corpora Cavernosa Severe Fibrosis: New Disposable Cavernotome C&R
M Rossello and A Mus
Center of Urology, Andrology and Sexology, Palma de Mallorca, Spain Introduction and objectives: Since their launching in the market in 1994, the use of the Cavernotomes C&R in the penile prosthesis implant in cases of severe fibrosis has avoided the risk involved when performing corporoplastias. Nowadays, and due to the actual sterilisation requirements, we have developed the one use disposable Cavernotomes C&R, made out of sterilizable Makrolon, material approved by the FDA, of less weight and easier to handle than the previous one made out of steel. Methods: We have selected among our patients a group of 20 impotent men, with corpora cavernosa severe fibrosis. Penile prosthesis implant was performed in all cases, using the steel Cavernotomes in 10 of them and the new disposable type in the rest of implants. We could observe that the disposable Cavernotomes, with their incisive brand new scraping arrows, removed more amount of fibrotic tissue in every in an outwards manoeuvre than the steel ones, reducing therefore the surgical time. Conclusions: We consider the disposable Cavernotome C&R indispensable in the penile prosthesis implant in cases of corpora cavernosa severe fibrosis, as they are easy to handle and reduce the surgical time decreasing consequently the risk of infections.
Penile Fracture Repair: A Color-Doppler Ultrasound (USS) Study of the Results P Gontero, P Sidhu, S Sriprasad and GH Muir Dept of Urology, King's College Hospital, London, UK Introduction and objectives: Traumatic penile fracture is a rare event. Among the more than 200 cases reported in the literature, the post-operative complications include penile curvature in a small percentage but there is no comment on erectile performance apart from being referred to as`satisfactory' in almost all patients. This report points out the USS color-doppler findings in four patients who had surgical repair five months before. Materials and methods: The USS color-doppler study was performed by means of an Acuson 128 6 9a10; 7± 10 Mhz extended frequency array transducer machine. Surgical repair was carried out in all cases via a subcoronal approach with a 3-0 PDS suture of the torn cavernosal albuginea. Erectile function was reported as normal by two patients (age 59 and 55 y), slightly decreased in one case (bilateral partial cavernous fracture total urethral transaction in a 32 y old) and weak in one case (51 y old). In the latter two the investigation included a dynamic phase following a 10 mcg PGE injection. Results: The results of the investigation were as follows: (1) Hyperechogenic spots produced by the non-absorbable suture materials, with no underlying Peyronie's changes; (2) Full length integrity of the cavernous arteries in all patients; and (3) Prompt peak flow rate b 0.35 mas in both the dynamic tests, with increased pattern of diastolic phase ( b 0.04 mas) in the case with bilateral rupture (strongly suggestive of venous leakage). Conclusions: Erectile dysfunction after surgical repair of a penile fracture does occur and may be explained either by a small venous leakage or by non-arteriogenicanon-venogenic mechanisms. No early fibrosis is seen in USS scanning, supporting immediate surgical repair of these injuries.
Penile fractures, long term evaluation of early surgical intervention MS El-Bahnasy, MA Gomha and MA Ghoneim Mansoura Urology and Nephrology Center, Mansoura Egypt Fifty-three patients were admitted to our center with penile fractures between 1981 and 1998. They underwent emergency closure of the tunica albuginea tear(s). Our diagnostic work up relied on the typical clinical presentation and penile ultrasonography to localize site of tear. However, two cases were misdiagnosed as tunica tear by ultrasonography and proved to be bleeding subcutaneous vessel with big haematoma. Ascending urethrogram was done whenever associated urethral injuries were suspected. Five cases (9.4%) were associated with urethral injuries that were repaired. Mean hospital stay was 2.7 d.
Follow-up period ranged from 4±120 months (mean 48 months). Three cases reported decreased erectile rigidity, two of whom had also mild angulation on erection but the three had satisfactory sexual intercourse. Two other cases showed small plaque at site of tunica repair without angulation or interference with degree of erection. All other cases are doing well with normal erectile function and without any angulations.
In conclusion, our results supports the good outcome of early surgical repair in terms of short hospital stay, low risk of persistent penile angulation and preservation of erectile function. Cavernosography may be required when clinical and ultrasonographic diagnosis are in doubt of tunical tear. Penile reconstruction remain a challenging surgery because of many cosmetic and functional (sexual and voiding) requirements that must be addressed. The reconstructed penis should be experienced with enough sensation to accommodate and retain a permanent erectile prosthetic implant for intercourse. The donor site should cause minimal morbidity and should be easy to conceal. Recently, microvascular free¯ap come closer to ful®lling these criteria.
Phaloplasty from Abdominal Tube to Free Forearm Vascular Flap and Prosthesis
In the present study, we treated eight female to male transsexuals and three men with penile traumatic amputation. Abdominal wall and thigh aps were fashioned into penises in the ®rst four cases. In the following seven patients were managed with a one stage total phaloplasty using lateral forearm innervated free¯ap. Penile prosthesis has been ®xed in the last ®ve cases to achieve a sexually active organ.
The most frequent complications were ®stulae that occurred in all the patients and required an average of three revisions. Penile prosthesis exposure occurred in two cases. However, the use of in¯atable prosthesis covered by a prolene mesh showed to decrease the incidence prosthesis exposure.
In a conclusion, penile reconstruction with lateral forearm free¯ap give a fully function penis and excellent patient satisfaction.
Functional Penile Reconstruction of an Amputated Penis Augmented with Lipodermal Flap: Case Report
KL Dabees Egypt
We encountered a case of complicated penile amputation since childhood during circumcision. The patient had 18 operations by different plastic and general surgeons. The end result at presentation was penis that formed partially by the penile stump then the distal half is formed by lipodermal¯ap transferred from the abdomen. Multiple scars in both thighs and lower abdomen was seen as a result of the previous surgeries.
The patient was unable to have intercourse as the distal half is weed and got bended during sexual trial we did penile panoramic ultrasound examination`Siescape' to determine the extent of the cavernous tissue and its function.
The decision was to remove the distal unfunction ap and to do penile lengthening procedure to get a functional length to the penis. This was done by cutting the suspensory ligament and to do skin plasty by using vascularized scrotal pedicled¯ap (`Dabees technique'). The result was a penis with good length and good function. To our knowledge we think this is the ®rst case like that is treated successfully with our technique.
Plaque Incision and Vein Graft for Peyronie's Disease the LUE Procedure MA Helal, AA Adeniyi, C Bettocchi, F Palumbo, DJ Ralph and JJ Pryor Institute of Urology, London, UK Introduction: The penile deformity due to Peyronie's disease is usually corrected by Nesbit operation. This involves the excision of the tunica and therefore results in a degree of penile shortening. This video demonstrates an alternative method of correcting the penile deformity without the loss of penile length. Methods: The penis is degloved and an artificial erection demonstrates the deformity and the site of the plaque. Buck's fascia is mobilised off the plaque, which may involve complete mobilisation of either the neurovascular bundle or urethra depending on the direction of the deformity. The plaque is then incised transversely and the flaccid penis stretched to outline the desired size of the graft. A graft is harvested from the long saphenous vein, trimmed to the size and then sutured into the tunical defect with continuous 3a0 prolene if the repeat artificial erection demonstrates a residual deformity a further plaque incision and vein graft may be necessary. Bucks fascia and the skin are closed with 3a0 vicryl . The deformity became apparent either immediately post operatively due to surgical error, after a mean of two months due to suture error or after a mean of 11 months due to progression of the disease. Revision surgery to correct the deformity was performed in 16 patients by either a redo-Nesbit operation, plaque incision and vein patch, plaque excision and dermal graft or insertion of penile prosthesis. An impaired erection occurred in nine patients, which was evident pre-operatively in six. A penile prosthesis was inserted in three of these patients. Penile shortening of b 2 cm occurred in 19 patients. Of these, three patients had a previous Nesbit operation, three had progression of the disease and three a severe post operative wound infection. Only four of the 19 found coitus impossible due to shortening and only one needed a penile lengthening procedure. Conclusion: The Nesbit operation should only be performed in patients who have a normal erectile capacity and where there is no sign of active disease. Absorbable sutures should be avoided, and patients warned about inevitable penile shortening, although this does not usually affect coital function. Material and methods: A prospective study of sixteen patients aged 17±32 years (mean 25 y) presenting with congenital penile curvature and ventral deviation. The deviation angle was in three patients 30 and in seven from 30±60 . Patients suffered difficult penetration at coitus and unacceptable cosmetic appearance. Eleven patients undergone modified Nesbit corporoplasty with placation sutures, five patients undergone incisional corporoplasty (longitudinal incision and transverse closure) Heineke-Mikuletz principle. The convex side of the curvature was exposed by a degloving subcoronal incision. Follow-up data were obtained by questionnaire and physical examination. Results: Fifteen patients were successfully treated. Excellent cosmetic results were achieved by both methods. Success was based on self documentation of a straight penis. All patients were potent. No major complications. Patients had mild discomfort and pain with erection which reduced with time. One patient with incisional corporoplasty needed a re-do for a residual deformity. Small areas of skin devascularization at subcoronal incisional site appeared in two patients and healed spontaneously within 4±6 weeks. No sensitivity changes in the glans penis was documented by either procedures. Mild penile shortening was observed but was not of patients concern, as the straight penis appeared longer than the angulated penis. Conclusion: Both techniques were effective, modified Nesbit procedure achieved higher rate of correction of curvature, yet incisional corporoplasty was easier, simpler and safer.
Corporoplasty for Congenital Penile Curvature
Penile Lengthening and Advancement
IA Mokhless and A Safwat Department of Urology, Alexandria University, Egypt
Objective: Although the use of surgery to increase functional length and the aesthetic appearance of the normal and the abnormal penis has become increasingly popular, some of the common surgical techniques currently in use are not without problems. We have tried a penile lengthening technique which seeks to minimize the problems. Methods: Nine potent adult patients (18±24 y) were evaluated: six with post traumatic (postcircumcision) phallic defects, (four granular and two granular plus distal corporal) and three with micropenis and ambiguous genitalia. Patients with traumatic phallic defects had ventral penoscrotal skin web. All patients had prominent suprapubic fat. Surgery was performed through a ventral Z plasty incision at the penoscrotal skin web. The suspensory ligament was divided to advance the corpora cavernosa. Syringe liposuction was applied to the suprapubic fat pad to elongate the short penis. Flaccid and erect penile Introduction: Development of a urethral stricture may occur following any type of phalloplasty. This paper describes the management of these strictures using buccal mucosa graft. Patients and methods: Refashioning of the urethra was performed in 16 female-to-male transsexual patients who had either had a pubic phalloplasty (15) or a forearm free flap phalloplasty (1). The indications for surgery were urethral stricture formation in 13 and absent urethra in three. A 2 cm strip of buccal mucosa was harvested from the inner cheek and used for the urethroplasty. The techniques used include a tube urethroplasty (11), patch urethroplasty (3) and a first stage onlay urethroplasty in two. The recipient bed included scar tissue, granulation tissue, dermis and fat. Results: The overall results showed patency was achieved in nine patients, four patients that had a tube urethroplasty developed an anastomotic stricture and two patients are awaiting second stage closure. One patient had a complete graft occlusion. Conclusion; Buccal mucosa is a known ideal urethral substitute and can be used in any type of phalloplasty. The graft takes reliability within 7 d and can grafted onto fat, dermis, granulation and scar tissue. Introduction: We report our experience at The Middlesex Hospital, London over a period of 10 y in phallic construction for female-to-male transsexuals using a pubic pedicled flap.
Materials and methods:
Sixty-five transsexual patients were considered eligible for surgical reassignment after a psychiatric assessment of at least 2 y. Technique: the phallus was formed by anterior abdominal wall skin, and the flap fashioned 10 cm wide and 11 cm length measured from the clitorid. The neourethra was fashioned in one stage at the same time of the phalloplasty up to 1993 and subsequently in two stages, in order to avoid urinary tract complications. In the first stage, the phallic urethra was fashioned using the right major labial flap, and turned through a skin tunnel into the neophallus. The second stage involves the isolation of the opposite major labia flap in a similar fashion. Results: Thirty-seven patients had a one-stage phalloplasty (Group A) and 28 had a two-stage operation (Group B). Group A: 5 patients did not want to have the neourethra. Urinary problems were frequent, being present in all but one patients. Group B: the incidence of neourethra complications was lower (86%). At the present time, 15 (60%) patients have completed the second stage of the urethroplasty and the flow was found to be satisfactory in 80% of them. Conclusions: Pubic phalloplasty is a simple, and relatively quick procedure, with minimal scarring in the donor area, esthetically acceptable to the patient and his partner, occasionally stiff enough for penetration. The major problem to be resolved is still the neourethra, as for all the other techniques. The ideal technique for phalloplasty still has to come.
Does Natural Erectile Function Improve Following Intracavernous Injection of Vasoactive Drugs
ID Sharlip
Pan Paci®c Urology, San Francisco, CA, USA Improvement in natural erections has been reported in approximately 9% of impotent men using intracavernous injections of vasoactive drugs for erection induction. The mechanisms which may account for this improvement include:
(1) Psychogenic effect (2) Improved cavernous hemodynamics (3) Prostaglandin-induced angiogenesis (4) Improved cavernous oxygenation (5) Cavernous smooth muscle hypertrophy (6) Normal episodic¯uctuations in erectile function A review of the basic science literature on this subject reveals several theoretical explanations for this phenomenon, but a review of the clinical literature reveals little convening evidence that physiologic andaor pharmacologic factors are reAfrican Society for Impotence Research Ð Second continental meeting sponsible for improvement in natural erections with intracavernous injection therapy. Furthermore, the prevalence of a placebo effect from impotence therapy exceeds the reported rate of improvement in natural or spontaneous erections.
The most plausible explanations for the spontaneous improvement in erections during or after intracavernous injection therapy are psychogenic effect and episodic variations in erectile function, rather than physiologic or pharmacologic factors.
However, intracavernous injection therapy started soon after radial prostatectomy may have a protective effect in preserving normal intracavernous physiology and erectile function in men being treated for prostate cancer.
Peyronie's Disease; Non-Surgical Therapy
San Francisco, CA, USA Despite recent research into the pathophysiology of Peyronie's disease and in multiple attempts at noel therapies, non-surgical treatment of Peyronie's Disease has never been shown to be kinder to patients than the natural history of the disease. Gelbard et al (1990) reported that 60 out of 97 men experienced improvement or no change in symptoms of Peyronie's disease with no treatment of any kind. It is well recognized that the pain of Peyronie's disease resolves spontaneously in the great majority of patients.
The list of non-surgical treatments for Peyronie's disease is very long, testifying to the inadequacy of these therapies. Three categories of non-surgical therapy exist: energy transfer, oral therapy and intralesionalaperi-lesional injection therapy.
Previous methods of energy transfer which have been applied to Peyronie's disease include ultrasonic therapy, short-wave diathermy, X-irradiation therapy and laser therapy. None proved signi®cantly effective. Most recently, extracorporeal shock wave therapy has been reported by Butz et al (1998) and Colombo et al (1998) but it is too early to know if this approach will work any better than other methods of energy transfer.
Oral therapy for Peyronie's disease has been attempted with many agents, including vitamin E, potassium aminobenzoate (Potaba), taoxifen, procarbazine and steroids. None of these agents has stood the test of time, although Vitamin E is used frequently because it is safe, inexpensive and convenient to take. The newest oral therapy to be tried is the old anti-in¯ammatoryacollagenase induction agent, colchicine. As reported by Akkus et al (1994) , colchicine has the possibility of reducing in¯ammation during the active phase of plaque formation, but few practitioners use this therapy because of its potential for serious side effects and its lack of proven ef®ciency.
Intra-lesional and peri-lesional injection therapy for Peyronie's disease has been attempted with many agents, including cortisone, hydrocortisone, dexamethasone, triamonolone, parathyroid hormone and orgotein. Gelbard et al (1993) tried intralesional injections of collagenase but were unable to prove clinical ef®ciency. Levine (1997) has used intra-lesional verapimil injections. He found that 54% of patients experienced an objective improvement in curature with only mild and transient side effects. However, two other investigators, Teloken et al (1998) and Nikolai et al (1998) had not been able to reproduce these results. Finally, intra-lesional injections of alpha interferon 2b were reported by Ahuja et al (1998) in a small series of men. They reported subjective improvement in curature in 12 out of 20 men (60%). In summary, recent investigations into non-surgical treatment of Peyronie's disease are interesting, but the conclusion still seems justi®ed that, other than surgery, clearly effective therapy for this disease does not yet exist. and satisfaction Some clinicians believe that the forms of organic FSD caused by inadequate pelvic blood¯ow may be treated pharmacologically. Clinical trials using new pharmacologic agents such as sildena®l, phentolamine, apomorphine and topical vasodilators have been, or will be, started in Europe and the United States. Currently, these agents should not be used in clinical practice because their safety and ef®ciency in females have not been proven yet. 
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